Diagnostic change: the power of DaTscan in Parkinson’s disease: A disease yet to be discovered

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder primarily characterized by motor symptoms such as bradykinesia, resting tremor, and muscle rigidity. Diagnostic accuracy is crucial for the effective treatment of the disease. This article examines the impact of using SPECT (Single Photon Emission Computed Tomography with high-affinity tracers for the dopamine transporter (DaTscan) in the diagnosis of Parkinson's disease, highlighting a study conducted at the Hospital of Barletta involving a population of 63 patients. This study will allow us to understand the diagnostic power of this method, both from a diagnostic and therapeutic point of view.